ANNAPOLIS, Md., Feb. 6 /PRNewswire-FirstCall/ -- PharmAthene, Inc.,
(Amex: PIP) a biodefense company developing medical countermeasures against
biological and chemical threats, announced today that David P. Wright,
President and Chief Executive Officer of PharmAthene, will present at the
BIO CEO & Investor Conference 2008, in New York, NY on Wednesday, February
13, 2008 at 2:00 p.m. The presentation is scheduled to take place in the
Basildon Room at the Waldorf Astoria Hotel.
PharmAthene's presentation will be available via webcast on the
company's website at http://www.pharmathene.com. A link to access the
webcast will be accessible from both the homepage and the investor
relations pages of the PharmAthene corporate website. For assistance,
contact Stacey Jurchison at 410-269-2610.
About PharmAthene, Inc.
PharmAthene (Amex: PIP) was formed to meet the critical needs of the
United States and its allies by developing and commercializing medical
countermeasures against biological and chemical weapons. PharmAthene's lead
programs include Valortim(TM) for the prevention and treatment of anthrax
infection and Protexia(R) for the prevention and treatment of morbidity and
mortality associated with exposure to chemical nerve agents. For more
information on PharmAthene, please visit http://www.pharmathene.com.
SOURCE PharmAthene Inc.
 back to top
Related links:
http://www.pharmathene.com
CONTACT:
Stacey Jurchison, Director, Corporate
Communications for PharmAthene, Inc., +1-410-269-2610, cell,
+1-410-474-8200, JurchisonS@PharmAthene.com
|
